Earnings History Data for Prometheus Biosciences (RXDX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Prometheus Biosciences

Prometheus Biosciences Inc. is a biotechnology company. It involved in the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of inflammatory bowel disease. Prometheus Biosciences Inc. is based in SAN DIEGO.

Release Date	Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
09-05-2023	AH	RXDX	Prometheus Biosciences	9,230	-0.86	-0.92	0.00	Prometheus Biosciences GAAP EPS of -$0.86 beats by $0.06, revenue of $1.11M beats by $0.65M [5/9/2023 6:02 PM]	194.26	-0.14 (-0.07%)	194.46	0.06 (0.03%)	21.50 - 197.83	802,597	1,050,000	420
Prometheus Biosciences GAAP EPS of -$0.86 beats by $0.06, revenue of $1.11M beats by $0.65M [5/9/2023 6:02 PM]
28-02-2023	AH	RXDX	Prometheus Biosciences	4,911	-0.90	-0.91	0.00	Prometheus Biosciences GAAP EPS of -$0.90 beats by $0.01, revenue of $0.65M beats by $0.18M [2/28/2023 5:48 PM]	121.53	-0.86 (-0.71%)	122.39	0.0 (0.00%)	21.50 - 125.65	432,121	450,000	13,296
Prometheus Biosciences GAAP EPS of -$0.90 beats by $0.01, revenue of $0.65M beats by $0.18M [2/28/2023 5:48 PM]
09-11-2022	AH	RXDX	Prometheus Biosciences	1,956	-0.90	-0.89	0.00	Prometheus Biosciences GAAP EPS of -$0.90 beats by $0.01, revenue of $0.97M beats by $0.39M [11/9/2022 5:19 PM]	49.22	-0.45 (-0.91%)	49.67	0.0 (0.00%)	21.50 - 63.13	572,690	510,000	4,403
Prometheus Biosciences GAAP EPS of -$0.90 beats by $0.01, revenue of $0.97M beats by $0.39M [11/9/2022 5:19 PM] Prometheus Biosciences Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Progress [Nov-09-22 04:01PM]
09-03-2022	AH	RXDX	Prometheus Biosciences	1,694	-0.77	-0.65	0.00		49.95	0.73 (1.48%)	51.68	2.46 (5.00%)	0.0 - 0.0	97,350	0	5,083
Prometheus Biosciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Highlights Recent Corporate Progress [Mar-09-22 04:01PM]
12-11-2021	PM	RXDX	Prometheus Biosciences	1,414	-0.70	-0.62	0.00	Prometheus Biosciences EPS misses by $0.12, beats on revenue [11/12/2021 8:38 AM]	36.37	-0.63 (-1.70%)	0.0	0.0 (0.00%)	16.11 - 38.99	286,102	220,000	0
Prometheus Biosciences EPS misses by $0.12, beats on revenue [11/12/2021 8:38 AM] Prometheus Biosciences Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate Progress [Nov-12-21 08:00AM]
11-08-2021	AH	RXDX	Prometheus Biosciences, Inc.	923.00	-0.49	-0.38	0.00	Prometheus Biosciences EPS misses by $0.10, beats on revenue [8/11/2021 4:46 PM]	21.62	-0.73 (-3.27%)	0.0	0.0 (0.00%)	16.11 - 30.64	30,629	50,000	0
Prometheus Biosciences EPS misses by $0.10, beats on revenue [8/11/2021 4:46 PM] Prometheus Biosciences Reports Second Quarter 2021 Financial Results and Highlights Recent Corporate Progress [Aug-11-21 04:01PM]